Could an arthritis drug prevent strokes after brain bleed?
NCT ID NCT06863480
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a drug called tocilizumab-aazg in 30 adults who have had a burst brain aneurysm. The goal is to see if the drug is safe and might help prevent strokes that can happen after the bleeding. Participants will receive the drug within 24 hours of the aneurysm rupture and be closely monitored for side effects like liver changes or low blood cell counts.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEURYSMAL SUBARACHNOID HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Florida Health (UF Health)
RECRUITINGGainesville, Florida, 32608, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a blood pressure cuff shield the brain after a severe stroke?
- Can a gentle ear zap calm the Brain's overactive 'Fight or Flight' response?
- Spinal zap may stop deadly brain artery spasms after aneurysm
- Brain pressure sensor may guide better recovery after aneurysm rupture
- Brain bleed breakthrough? new drug could stop fluid buildup without surgery
- Nerve block may boost brain recovery after hemorrhagic stroke